Pressure-Controlled Intermittent Coronary Sinus Occlusion: A Novel Approach to Improve Microvascular Flow and Reduce Infarct Size in STEMI
Why the study?
Despite successful primary PCI for STEMI, myocardial salvage is frequently suboptimal and microvascular dysfunction contributes directly to poor outcomes, highlighting the need for novel therapies like PiCSO.
Does Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) improve microvascular flow and reduce infarct size in patients with STEMI undergoing primary PCI?
Population
Patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
PiCSO may enhance myocardial salvage in STEMI with microvascular dysfunction; RCT evidence extends prior feasibility data and warrants larger outcome trials.
Structured PICO
Does Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) improve microvascular flow and reduce infarct size in patients with STEMI undergoing primary PCI?
P
Population
Patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI)
I
Intervention
Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) during primary PCI
Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) is a novel technology designed to mitigate microvascular dysfunction during primary PCI for STEMI, with randomized trials currently ongoing to establish its efficacy.
Cite This Study
Gibson et al. (2022) studied this question.